Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$868M |
| 2 |
Amazon
AMZN
|
+$726M |
| 3 |
UnitedHealth
UNH
|
+$571M |
| 4 |
Rivian
RIVN
|
+$559M |
| 5 |
TJX Companies
TJX
|
+$441M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.09B |
| 2 |
NVIDIA
NVDA
|
+$762M |
| 3 |
L3Harris
LHX
|
+$742M |
| 4 |
Zurn Elkay Water Solutions
ZWS
|
+$497M |
| 5 |
Texas Instruments
TXN
|
+$477M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.51% |
| 2 | Healthcare | 18.41% |
| 3 | Consumer Discretionary | 11.39% |
| 4 | Financials | 9.7% |
| 5 | Industrials | 8.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARGO
701
DELISTED
Argo Group International Holdings, Ltd.
ARGO
| $28.4M | 0.01% |
488,609
-66,965
| -12% | -$3.77M |
|
702
Marcus & Millichap
MMI
$1.2B
| $28.3M | 0.01% |
549,287
+1,724
| +0.3% | +$80.4K |
|
703
Kodiak Sciences
KOD
$2.5B
| $28.1M | 0.01% |
331,067
-4,315
| -1% | -$439K |
|
704
Olema Pharmaceuticals
OLMA
$977M
| $28M | 0.01% |
2,995,440
+519,610
| +21% | +$10.8M |
|
705
Fluence Energy
FLNC
$1.58B
| $27.9M | 0.01% |
+785,445
| New | +$26.8M |
|
706
Brookfield
BN
$102B
| $27.7M | 0.01% |
851,520
+234,258
| +38% | +$7.41M |
|
707
FormFactor
FORM
$6.51B
| $27.6M | 0.01% |
603,881
+221,355
| +58% | +$9.06M |
|
708
Dutch Bros
BROS
$8.86B
| $27.3M | 0.01% |
535,678
-137,910
| -20% | -$7.66M |
|
709
Halozyme
HALO
$9.88B
| $27M | 0.01% |
671,571
+13,176
| +2% | +$492K |
|
710
Levi Strauss
LEVI
$9.49B
| $27M | 0.01% |
1,078,721
-109,803
| -9% | -$2.83M |
|
711
HubSpot
HUBS
$12.9B
| $27M | 0.01% |
40,948
-3,267
| -7% | -$2.47M |
|
712
West Fraser Timber
WFG
$5.21B
| $27M | 0.01% |
281,954
-197,180
| -41% | -$17.1M |
|
713
Sanofi
SNY
$107B
| $26.8M | 0.01% |
535,043
-31,789
| -6% | -$1.57M |
|
714
Consolidated Edison
ED
$41.4B
| $26.8M | 0.01% |
313,761
-480,974
| -61% | -$37.8M |
|
715
Norfolk Southern
NSC
$75.4B
| $26.4M | 0.01% |
88,545
+37,497
| +73% | +$10.5M |
|
716
Reinsurance Group of America
RGA
$15.5B
| $26.4M | 0.01% |
240,679
+198,549
| +471% | +$22.1M |
|
717
Century Casinos
CNTY
$32.9M
| $26.4M | 0.01% |
2,163,351
-132,708
| -6% | -$1.87M |
|
718
W.W. Grainger
GWW
$64.2B
| $26.3M | 0.01% |
50,746
-49,987
| -50% | -$23.6M |
|
719
First American
FAF
$7.98B
| $26.2M | 0.01% |
335,136
-12,852
| -4% | -$959K |
|
|
NUVL
720
DELISTED
Nuvalent
NUVL
| $26.1M | 0.01% |
1,418,047
-9,929
| -0.7% | -$221K |
|
721
Becton Dickinson
BDX
$46.4B
| $26.1M | 0.01% |
106,351
+29,279
| +38% | +$7.01M |
|
722
Booz Allen Hamilton
BAH
$8.44B
| $26.1M | 0.01% |
307,573
-6,343
| -2% | -$535K |
|
723
Biomea Fusion
BMEA
$88.2M
| $26M | 0.01% |
3,527,286
+325,921
| +10% | +$3.45M |
|
724
Janus Henderson Short Duration Income ETF
VNLA
$3.34B
| $25.8M | 0.01% |
520,521
+239,423
| +85% | +$11.9M |
|
725
CSX Corp
CSX
$94B
| $25.6M | 0.01% |
681,368
+202,585
| +42% | +$7.14M |
|
Similar funds
Janus Henderson Group's Q4 2021 Portfolio in Review
As of Q4 2021, Janus Henderson Group held 2,654 positions worth $240B, up 4.9% from $229B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Janus Henderson Group's Q4 2021 filing shows 464 new, 1,324 increased, 690 reduced and 110 closed positions. Its largest new stake was Rivian: 4,856,003 shares worth $504M. The largest sale was Meta Platforms (Facebook), an estimated $1.09B.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q4 2021 buy was Rivian: 4,856,003 shares worth $504M.
- Janus Henderson Group added most to Apple in Q4 2021, an estimated $868M increase.
- Janus Henderson Group's biggest Q4 2021 reduction was Meta Platforms (Facebook), cutting an estimated $1.09B.
- Janus Henderson Group fully exited Acceleron Pharma in Q4 2021, selling an estimated $274M.
- Janus Henderson Group's ten largest holdings make up 25% of its $240B portfolio in Q4 2021.
- Janus Henderson Group opened 464 new positions and closed 110 in Q4 2021.
- Janus Henderson Group's portfolio value rose 4.9% quarter-over-quarter to $240B.
Based on Janus Henderson Group's 13F filing for Q4 2021, filed 14 Feb 2022.